Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kaposiform lymphangiomatosis treated with multimodal therapy improves coagulopathy and reduces blood angiopoietin‐2 levels
Janet E. Crane, Jackie Manfredo, Elisa Boscolo, et al.
Pediatric Blood & Cancer (2020) Vol. 67, Iss. 9
Open Access | Times Cited: 23

Showing 23 citing articles:

Capillary malformations
Adrienne M. Hammill, Elisa Boscolo
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 10
Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition
Guy Chowers, Gadi Abebe‐Campino, Hana Golan, et al.
Pediatric Research (2022) Vol. 94, Iss. 6, pp. 1911-1915
Open Access | Times Cited: 33
Lymphatic Anomalies in Children: Update on Imaging Diagnosis, Genetics, and Treatment
Elizabeth Snyder, Asha Sarma, Alexandra J. Borst, et al.
American Journal of Roentgenology (2022) Vol. 218, Iss. 6, pp. 1089-1101
Closed Access | Times Cited: 28
Kaposiform lymphangiomatosis: Diagnosis, pathogenesis, and treatment
C. Griffin McDaniel, Denise M. Adams, Kimberley E. Steele, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. 4
Open Access | Times Cited: 16
How we use angiopoietin‐2 in the diagnosis and management of vascular anomalies
Elissa Engel, Timothy D. Le Cras, Kiersten Ricci
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 5
Open Access | Times Cited: 6
NRASQ61R mutation drives elevated angiopoietin‐2 expression in human endothelial cells and a genetic mouse model
Patricia Pastura, C. Griffin McDaniel, Sara Alharbi, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 7
Open Access | Times Cited: 4
How we approach the use of sirolimus and new agents: Medical therapy to treat vascular anomalies
Kristin A. Shimano, Whitney Eng, Denise M. Adams
Pediatric Blood & Cancer (2022) Vol. 69, Iss. S3
Closed Access | Times Cited: 19
NRASQ61R mutation in human endothelial cells causes vascular malformations
Elisa Boscolo, Patricia Pastura, Sandra Schrenk, et al.
Angiogenesis (2022) Vol. 25, Iss. 3, pp. 331-342
Open Access | Times Cited: 19
Primary splenic involvement in kaposiform lymphangiomatosis: A case report
Ethan Covil, Robert Gates
International Journal of Surgery Case Reports (2025) Vol. 127, pp. 110868-110868
Open Access
Complex lymphatic anomalies
Dana Alkhulaifat, Karen I. Ramirez‐Suarez, Hansel J. Otero, et al.
Pediatric Radiology (2025)
Closed Access
RAS Pathway Mutations and Therapeutics in Vascular Anomalies
Sara Alharbi, Svatava Merkle, Adrienne M. Hammill, et al.
Pediatric Blood & Cancer (2025)
Open Access
Sirolimus in the treatment of kaposiform lymphangiomatosis
Jiangyuan Zhou, Kaiying Yang, Siyuan Chen, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 22
Kaposiform Lymphangiomatosis
Antonio R. Pérez‐Atayde, Larisa V. Debelenko, Alyaa Al‐Ibraheemi, et al.
The American Journal of Surgical Pathology (2022) Vol. 46, Iss. 7, pp. 963-976
Closed Access | Times Cited: 16
Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines
Themis‐Areti A. Andreoti, Sebastian Berg, Annegret Holm, et al.
Lymphatic Research and Biology (2023)
Closed Access | Times Cited: 6
Targeted therapies for vascular malformations
Gavin Kane, Israel Fernández‐Pineda
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Osteopathy in Complex Lymphatic Anomalies
Ernesto Solorzano, Andrew L Alejo, Hope C. Ball, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8258-8258
Open Access | Times Cited: 8
Refractory kaposiform lymphangiomatosis relieved by splenectomy
Yuru Lan, Jiangyuan Zhou, Tong Qiu, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 1
Medical Therapeutics for the Treatment of Vascular Anomalies
Kiersten Ricci
Oral and Maxillofacial Surgery Clinics of North America (2023) Vol. 36, Iss. 1, pp. 125-136
Closed Access | Times Cited: 1
Lymphatic vascular anomalies and dysfunction
Christian El Amm, Federico Silva-Palacios, Xin Geng, et al.
Elsevier eBooks (2022), pp. 301-310
Closed Access | Times Cited: 1
Lymphatic Development and Implications for Diagnosis and Therapy
Sudhen B. Desai, Ionela Iacobas, Stanley G. Rockson
Lymphatic Research and Biology (2021) Vol. 19, Iss. 1, pp. 31-35
Closed Access | Times Cited: 1
Complex Thoracic Lymphatic Disorders of Adults
Hassan Mujahid, Anita Gupta, Adrienne M. Hammill, et al.
Springer eBooks (2023), pp. 369-387
Closed Access
Kaposiform lymphangiomatosis with Kasabach–Merritt phenomenon
L. A. Khachatryan, Galina Novichkova, M. S. Vasilieva, et al.
Pediatric Hematology/Oncology and Immunopathology (2023) Vol. 22, Iss. 2, pp. 142-151
Open Access
Kaposiform lymphangiomatosis presenting with a Group AStreptococcuspericardial effusion
Taylor Koerner, Mehul D. Patel, Vinay Pai, et al.
BMJ Case Reports (2022) Vol. 15, Iss. 3, pp. e246250-e246250
Open Access
Page 1

Scroll to top